A rise in ageing population has been found to be the major causative factor for development of Parkinson’s disease. Parkinson’s disease is the second-most common chronic and progressive neurodegenerative disorder featuring the cardinal symptoms of postural instability, bradykinesia, akinesia and tremors due to loss of dopamine producing neurons in substantia nigra of the mid-brain. The mean age of onset of Parkinson’s disease is 55 to 60 years. According to the Parkinson’s Disease Foundation (PDF), approximately 10 million people are estimated to currently live with Parkinson’s disease globally. There are multiple treatment options available in the market to treat patients living with Parkinson’s disease. These include chemotherapy, stem cell therapy, physical therapy and surgical treatment. Among drug therapies, the most potent medication is levodopa/Carbidopa therapy.

1. Press Release Discription :
Deep Brain Stimulation Devices Market for Parkinson's disease Expected to Reach
USD 9.4 Billion Globally in 2019: Transparency Market Research
Transparency Market Research has released a new market report titled " Deep Brain
Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia-
Pacific and Latin America)- Global Industry Analysis, Size, Share, Growth, Trends
and Forecast, 2013 - 2019," the global deep brain stimulation devices market was valued
at USD 4.5 billion in 2012 and is expected to grow at a CAGR of 11.0% from 2013 to 2019,
to reach an estimated value of USD 9.4 billion in 2019.
Rising number of neurological disorders such ischemic stroke, Alzheimer's disease, essential
tremors, trauma and especially Parkinsonism are primary factors responsible for the growth
of deep brain stimulation devices market. Parkinson's disease is the second most common
chronic and progressive neurodegenerative disorder characterized by postural instability,
bradykinesia, akinesia and tremors due to loss of dopamine producing neurons in substantia
nigra of mid-brain.
Transparency Market Research
Deep Brain Stimulation
Devices Market - Global
Industry Analysis, Size,
Share, Growth, Trends and
Forecast, 2013 - 2019
Single User License: US $ 4595
Multi User License: US $ 7595
Corporate User License: US $ 10595
Buy Now
Request Sample
Published Date: April 2014
91 Pages Report

2. In addition, rise in geriatric population along with augmented demand for minimally invasive
surgical techniques have boosted the overall growth of this market. Moreover, increase in
preference of patients and healthcare professionals to adopt surgical DBS devices over drug
therapy owing to its significantside effects and lack of effectiveness is further expected to
drive the market in coming years.
According to the Parkinson's DiseaseFoundation (PDF), it has been estimated that
approximately 10 million people worldwide and one million Americans are living with
Parkinson's disease. Among these, in U.S. approximately 60,000 people are diagnosed with
Parkinson's disease each year. There are different treatment options available for
Parkinson's disease that include drug therapy, surgical therapy, physical therapy and stem
cell therapy. However, DBS surgical therapy is mostly preferred in advanced stages of the
disease while in early stages chemotherapy is used.
The global deep brain stimulation devices market is segmented geographically into North
America, Europe, Asia-Pacific and Latin America. Among these, North America accounts for
the largest market share of deep brain stimulation devices market and is valued to be more
than USD 2billion in 2012 owing to rise in number of patients who are adopting surgical
therapy for Parkinson's disease and rise in geriatric population. In addition, favorable
government reimbursement policies and growing side effects from medication treatment are
further expected toboost the growth of the market in this region. The market for North
America is followed by Europe, Latin America and Asia-Pacific. Contributing factors for the
lowest market share of deep brain stimulation devices in Asia-Pacific include lack of
favorable government insurance policies and high cost for surgical treatment.
The major players of this market include Medtronic, Inc., St. Jude Medical, Inc. and Boston
Scientific Corporation. Other companies active in this market include Sapiens Neuro, Aleva
Neurotherapeutics SA, ANM Adaptive Neuromodulation GmbH, Synaptix, Neurosigma, Inc.
and Neurospace. The DBS products of these "Other" players are not yet commercially
available in the market since they are still under clinical trials. Companies are heavily
focusing on introducing innovative products that are easy to use for physicians as well as
patients. These companies are also aiming to make them more portable.
The global Deep brain stimulation devices market for Parkinson's disease is segmented as
follows:
Deep Brain Stimulation Devices Market, By Geography
 North America
 U.S.
 Canada
 Europe

3. o Germany
o U.K.
o France
o Italy
o Spain
o Poland
o Netherlands
o Greece
o Belgium
o Portugal
 Asia-Pacific
o Australia
o New Zealand
o Japan
o India
o China
 Latin America
o Brazil
o Mexico
o Argentina
o Chile
Browse all Medical Devices Market Research Reports @
http://www.transparencymarketresearch.com/medical-devices-market-reports-
6.html

4. Browse all Medical Devices Market Research Reports @
http://www.transparencymarketresearch.com/medical-devices-market-reports-
6.html
Table of Content
Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease
(2012 & 2019)
Chapter 3 Global Deep Brain Stimulation Devices Market for Parkinson’s Disease
Dynamics
3.1 Introduction
3.1.1 Drivers
3.1.1.1 Aging population inducing chronic neurological disorders such as
Parkinson’s and Alzheimer’s
3.1.1.2 Technological advancements driving the growth of DBS
3.1.1.3 Favorable reimbursement policies
3.1.1.4 Increasing demand for minimally invasive surgeries
3.1.2 Restraints
3.1.2.1 Implementation of Affordable Care Act in the U.S.
3.1.2.2 Risks Involved in DBS Procedures
3.1.3 Opportunities

5. 3.2 Porter’s Five Force Analysis: Global Deep Brain Stimulation Devices Market for
Parkinson’s Disease
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis of the Global Deep Brain Stimulation Devices Market for
Parkinson’s Disease, by Geography
Related & Recently Published Reports by Transparency Market Research
 Antibacterial Drugs Market:
http://www.transparencymarketresearch.com/antibacterial-drugs-
market.html
 Seasonings and Spices Market:
http://www.transparencymarketresearch.com/seasoning-spices-
market.html
 Surgical Equipment Market:
http://www.transparencymarketresearch.com/surgical-equipment-
market.html
 Polymethyl Methacrylate (PMMA) Market:
http://www.transparencymarketresearch.com/polymethyl-methacrylate-
market.html
 Prenatal and New-born Genetic Testing Market:
http://www.transparencymarketresearch.com/prenatal-new-born-genetic-
testing.html
Chapter 4 Deep Brain Stimulation Devices Market for Parkinson’s Disease, By
Geography
4.1 Overview
4.1.1 Comparative Analysis: Global Deep Brain Stimulation Devices Market, By
Geography, 2012 & 2019 (Value %)
4.2 North America

6. 4.2.1 U.S.
4.2.1.1 U.S. Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.2.2 Canada
4.2.2.1 Canada Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.3 Europe
4.3.1 Germany
4.3.1.1 Germany Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.3.2 U.K.
4.3.2.1 U.K. Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.3.3 France
4.3.3.1 France Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.3.4 Italy
4.3.4.1 Italy Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.3.5 Spain
4.3.5.1 Spain Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.3.6 Poland
4.3.6.1 Poland Deep brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.3.7 Netherlands
4.3.7.1 Netherlands Deep brain Stimulation Devices Market Revenue for
Parkinson’s Disease, 2011 – 2019 (USD Million)
4.3.8 Greece

7. 4.3.8.1 Greece Deep brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.3.9 Belgium
4.3.9.1 Belgium Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.3.10 Portugal
4.3.10.1 Portugal Deep Brain Stimulation Devices Market Revenue for
Parkinson’s Disease, 2011 – 2019 (USD Million)
4.4 Asia Pacific
4.4.1 Australia
4.4.1.1 Australia Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.4.2 New Zealand
4.4.2.1 New Zealand Deep Brain Stimulation Devices Market Revenue for
Parkinson’s Disease, 2011 – 2019 (USD Million)
4.4.3 Japan
4.4.3.1 Japan Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.4.4 India
4.4.4.1 India Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.4.5 China
4.4.5.1 China Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.5 Latin America
4.5.1 Brazil
4.5.1.1 Brazil Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.5.2 Mexico

8. 4.5.2.1 Mexico Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.5.3 Argentina
4.5.3.1 Argentina Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
4.5.4 Chile
4.5.4.1 Chile Deep Brain Stimulation Devices Market Revenue for Parkinson’s
Disease, 2011 – 2019 (USD Million)
Chapter 5 Global Deep Brain Stimulation Devices Market Share Analysis
5.1 Market Share Analysis by Key Players of Global Deep Brain Stimulation Devices Market
for Parkinson’s Disease
5.1.1 Global Deep Brain Stimulation Devices for Parkinson’s Disease Market Share
Analysis, by Key Players, 2012 (%)
Chapter 6 Recommendations
6.1 Success strategies
6.1.1 Rigorous research and development (R&D) activities
6.1.2 Medical device manufacture outsourcing
6.1.3 Increase public and professional awareness
6.1.4 Investing in emerging economies
Chapter 7 Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Profile
7.1.2 Financial Overview
7.1.3 Product Portfolio

9. 7.1.4 Business Strategies
7.1.4.1 Expansion of geographical footprint
7.1.4.2 Acquisitions
7.1.4.3 Recent Developments
7.2 MEDTRONIC, Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategies
7.2.4.1 Research and Development investments
7.2.4.2 Patent filling
7.2.4.3 Recent Developments
7.3 St Jude Medical, Inc.
7.3.1 Company Profile
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategies
7.3.4.1 Global expansion with technology advancement
7.3.4.2 Recent Developments
7.4 Sapiens Neuro
7.4.1 Company Overview
7.4.2 Product Portfolio
7.4.3 Business Strategy
7.4.3.1 Business through innovation and excellence
7.4.4 Recent Developments

10. 7.5 Aleva Neurotherapeutics SA
7.5.1 Company Overview
7.5.2 Product Portfolio
7.5.3 Business Strategy
7.5.3.1 Patent filling
About Us:
Transparency Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants,
who use proprietary data sources and various tools and techniques to gather, and analyze
information. Our business offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Browse all Chemical & Materials Market Research Reports @
http://www.transparencymarketresearch.com/chemical-market-reports-2.html